Moneycontrol PRO
HomeNewsBusinessOmicron may be less severe in young and old, but not 'mild': WHO

Omicron may be less severe in young and old, but not 'mild': WHO

Janet Diaz, WHO lead on clinical management, said early studies showed there was a reduced risk of hospitalisation from the variant first identified in southern Africa and Hong Kong in November compared with Delta.

January 06, 2022 / 22:37 IST
Representative Image. (Source: Reuters)

The more infectious Omicron variant of COVID-19 appears to produce less severe disease than the globally dominant Delta strain, but should not be categorised as "mild", World Health Organization (WHO) officials said on Thursday.

Janet Diaz, WHO lead on clinical management, said early studies showed there was a reduced risk of hospitalisation from the variant first identified in southern Africa and Hong Kong in November compared with Delta.

There appears also to be a reduced risk of severity in both younger and older people, she told a media briefing from WHO headquarters in Geneva.

The remarks on the reduced risks of severe disease chime with other data, including studies from South Africa and England, although she did not give further details about the studies or ages of the cases analysed.

The impact on the elderly is one of the big unanswered questions about the new variant as most of the cases studied so far have been in younger people.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"While Omicron does appear to be less severe compared to Delta, especially in those vaccinated, it does not mean it should be categorised as mild," director general Tedros Adhanom Ghebreyesus said at the same briefing in Geneva.

"Just like previous variants, Omicron is hospitalising people and it is killing people."

He warned of a "tsunami" of cases as global infections soar to records fuelled by both Omicron and Delta, healthcare systems are overwhelmed, and governments struggle to tame the virus, which has killed more than 5.8 million people.

'BILLIONS COMPLETELY UNPROTECTED'

Tedros repeated his call for greater equity globally in the distribution of and access to vaccines.

Based on the current rate of vaccine rollout, 109 countries will miss the WHO's target for 70 percent of the world's population to be fully vaccinated by July, Tedros added. That aim is seen as helping end the acute phase of the pandemic.

"Booster after booster in a small number of countries will not end a pandemic while billions remain completely unprotected," he said.

WHO adviser Bruce Aylward said 36 nations had not even reached 10 percent vaccination cover. Among severe patients worldwide, 80 percent were unvaccinated, he added.

In its weekly epidemiological report on Thursday, the WHO said cases increased by 71 percent, or 9.5 million, in the week to Jan. 2 from a week earlier, while deaths fell by 10 percent, or 41,000.

Another variant B.1.640 - first documented in multiple countries in September 2021 - is among those being monitored by the WHO but is not circulating widely, said the WHO's technical lead on COVID-19, Maria van Kerkhove.

There are two other categories of greater significance the WHO uses to track variants: "variant of concern", which includes Delta and Omicron, and "variant of interest."

Reuters
first published: Jan 6, 2022 10:37 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347